サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1559638

RSV診断の世界市場

RSV Diagnostics

出版日
ページ情報
英文 233 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
RSV診断の世界市場
出版日: 2024年09月24日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 233 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

RSV診断の世界市場は2030年までに12億米ドルに達する見込み

2023年に7億6,840万米ドルと推定されたRSV診断の世界市場は、2030年には12億米ドルに達し、分析期間2023-2030年のCAGRは6.9%で成長すると予測されます。RSV診断キット＆アッセイは、本レポートで分析したセグメントの1つであり、CAGRは7.7％を記録し、分析期間終了時には6億8,660万米ドルに達すると予測されています。RSV診断 Instruments分野の成長率は、分析期間中CAGR 6.3％と推定されます。

米国市場は2億350万米ドルと推定、中国はCAGR 11.6％で成長予測

米国のRSV診断市場は、2023年に2億350万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに3億580万米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは11.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.7%と7.0%と予測されています。欧州では、ドイツがCAGR 3.7%で成長すると予測されています。

世界のRSV診断市場- 主要動向と促進要因まとめ

RSV診断とは何か、なぜ公衆衛生にとって重要なのか
呼吸器合胞体ウイルス（RSV）診断には、肺や呼吸器に感染を引き起こす一般的な呼吸器ウイルスであるRSVの存在を検出するためのさまざまな検査や処置が含まれます。RSVは乳幼児、幼児、高齢者、免疫不全者にとって特に危険で、気管支炎や肺炎などの重篤な呼吸器疾患を引き起こします。早期かつ正確な診断は、ウイルスの蔓延を防ぎ、タイムリーな介入を可能にするため、効果的な管理と治療のために極めて重要です。RSV診断には、ポリメラーゼ連鎖反応（PCR）のような分子検査、抗原検出検査、血清学的検査が含まれ、それぞれ感度、特異度、所要時間が異なります。RSVが社会的弱者に与える影響に対する認識が高まるにつれ、効率的で迅速な診断ソリューションに対する需要は、臨床およびPOCの両方で高まっています。

技術の進歩はRSV診断市場をどのように形成しているか？
技術の進歩は、RSV診断の精度、スピード、アクセシビリティを高める上で極めて重要な役割を果たしています。数分で結果が得られる迅速抗原検査の開発は、ポイントオブケア診断に革命をもたらし、RSV検査を外来や救急医療の現場でより利用しやすくしています。分子診断学、特にリアルタイムPCRと核酸増幅検査（NAAT）の進歩は、より高い感度と特異性を提供し、検体中の低ウイルス量の検出を可能にしています。RSVとインフルエンザやCOVID-19などの他の呼吸器病原体を同時に検査できるマルチプレックスパネルのイントロダクションは、診断効率を向上させ、包括的な呼吸器疾患管理を可能にしています。さらに、デジタルプラットフォームや遠隔医療の利用により、遠隔診断や診察が容易になり、患者の治療へのアクセスが向上しています。このような技術革新は、RSV診断の適用範囲と有効性を拡大し、先進地域と発展途上地域の両方での採用を促進しています。

RSV診断市場にはどのような課題と機会が存在するか？
RSV診断市場は、高度な診断検査のコスト高、検査精度のばらつき、複雑な診断機器を操作する熟練者の必要性など、いくつかの課題に直面しています。PCRのような分子診断検査はコストが高いため、特に低資源環境では普及の障壁となりうる。さらに、異なる検査の感度や特異度のばらつきは、偽陽性や偽陰性を引き起こし、臨床的な意思決定に影響を与える可能性があります。しかし、このような課題は、成長と技術革新の大きな機会となっています。RSVに対する認識の高まりと公衆衛生への影響は、世界の呼吸器疾患の増加と相まって、効果的で手頃な価格の診断ソリューションに対する需要を促進しています。早期発見と予防ヘルスケアへの注目の高まりは、市場の可能性をさらに高めています。さらに、遠隔医療や遠隔診断の拡大は、RSV診断プロバイダーが革新的で利用しやすいソリューションを提供する新たな機会を生み出しています。

RSV診断市場の成長を牽引している要因とは？
RSV診断市場の成長は、特に乳幼児、高齢者、免疫不全集団におけるRSV感染の発生率の上昇など、いくつかの要因によって牽引されています。迅速抗原検査、リアルタイムPCR、マルチプレックス・パネル、デジタル診断の技術的進歩により、RSV診断の精度、スピード、アクセシビリティが向上し、採用が進んでいます。また、早期診断、予防医療、RSVとインフルエンザやCOVID-19などの他の呼吸器疾患との鑑別の必要性への注目が高まっていることも、市場の成長に寄与しています。さらに、特に新興市場における医療インフラの拡大や、プライマリケア環境におけるポイントオブケア検査の採用拡大も、RSV診断の需要を押し上げています。患者の転帰を改善し、入院を減らし、RSVの蔓延を最小限に抑えることに重点を置くことが、RSV診断市場をさらに前進させています。

調査対象企業の例（全166件）

  • Abbott Molecular
  • Apollo Diagnostics
  • Becton, Dickinson and Company
  • Biomeb
  • BIOMED Labordiagnostik GmbH
  • bioMerieux SA
  • Bioperfectus Technologies
  • BioReference Laboratories, Inc.
  • Cellgen Diagnostics
  • Cepheid

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP14514

Global RSV Diagnostics Market to Reach US$1.2 Billion by 2030

The global market for RSV Diagnostics estimated at US$768.4 Million in the year 2023, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. RSV Diagnostics Kits & Assays, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$686.6 Million by the end of the analysis period. Growth in the RSV Diagnostics Instruments segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$203.5 Million While China is Forecast to Grow at 11.6% CAGR

The RSV Diagnostics market in the U.S. is estimated at US$203.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$305.8 Million by the year 2030 trailing a CAGR of 11.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global RSV Diagnostics Market - Key Trends and Drivers Summarized

What Are RSV Diagnostics and Why Are They Critical for Public Health?
Respiratory Syncytial Virus (RSV) diagnostics involve a range of tests and procedures designed to detect the presence of RSV, a common respiratory virus that causes infections in the lungs and respiratory tract. RSV is particularly dangerous for infants, young children, the elderly, and immunocompromised individuals, leading to severe respiratory illnesses such as bronchiolitis and pneumonia. Early and accurate diagnosis is crucial for effective management and treatment, as it helps prevent the spread of the virus and enables timely intervention. RSV diagnostics include molecular tests like Polymerase Chain Reaction (PCR), antigen detection tests, and serological assays, each providing different levels of sensitivity, specificity, and turnaround times. As the awareness of RSV's impact on vulnerable populations grows, the demand for efficient and rapid diagnostic solutions is rising in both clinical and point-of-care settings.

How Are Technological Advancements Shaping the RSV Diagnostics Market?
Technological advancements are playing a pivotal role in enhancing the accuracy, speed, and accessibility of RSV diagnostics. The development of rapid antigen tests that provide results in minutes is revolutionizing point-of-care diagnostics, making RSV testing more accessible in outpatient and emergency care settings. Advances in molecular diagnostics, particularly in real-time PCR and nucleic acid amplification tests (NAATs), are offering higher sensitivity and specificity, allowing for the detection of even low viral loads in samples. The introduction of multiplex panels that can simultaneously test for RSV and other respiratory pathogens, such as influenza and COVID-19, is improving diagnostic efficiency and enabling comprehensive respiratory illness management. Additionally, the use of digital platforms and telemedicine is facilitating remote diagnosis and consultation, enhancing patient access to care. These technological innovations are expanding the scope and effectiveness of RSV diagnostics, driving their adoption in both developed and developing regions.

What Challenges and Opportunities Exist in the RSV Diagnostics Market?
The RSV diagnostics market faces several challenges, including high costs of advanced diagnostic tests, variability in test accuracy, and the need for skilled personnel to operate complex diagnostic equipment. The high cost of molecular diagnostic tests, such as PCR, can be a barrier to widespread adoption, particularly in low-resource settings. Additionally, variations in the sensitivity and specificity of different tests can lead to false positives or negatives, affecting clinical decision-making. However, these challenges present significant opportunities for growth and innovation. The increasing awareness of RSV and its impact on public health, coupled with the rise in global respiratory illnesses, is driving demand for effective and affordable diagnostic solutions. The growing focus on early detection and preventive healthcare is further boosting market potential. Moreover, the expansion of telehealth and remote diagnostics is creating new opportunities for RSV diagnostics providers to offer innovative and accessible solutions.

What Factors Are Driving the Growth of the RSV Diagnostics Market?
The growth in the RSV Diagnostics market is driven by several factors, including the rising incidence of RSV infections, particularly among infants, the elderly, and immunocompromised populations. Technological advancements in rapid antigen tests, real-time PCR, multiplex panels, and digital diagnostics are enhancing the accuracy, speed, and accessibility of RSV diagnostics, driving their adoption. The increasing focus on early diagnosis, preventive healthcare, and the need to differentiate RSV from other respiratory illnesses, such as influenza and COVID-19, is also contributing to market growth. Additionally, the expansion of healthcare infrastructure, particularly in emerging markets, and the growing adoption of point-of-care testing in primary care settings are boosting the demand for RSV diagnostics. The emphasis on improving patient outcomes, reducing hospitalizations, and minimizing the spread of RSV is further propelling the RSV diagnostics market forward.

Select Competitors (Total 166 Featured) -

  • Abbott Molecular
  • Apollo Diagnostics
  • Becton, Dickinson and Company
  • Biomeb
  • BIOMED Labordiagnostik GmbH
  • bioMerieux SA
  • Bioperfectus Technologies
  • BioReference Laboratories, Inc.
  • Cellgen Diagnostics
  • Cepheid

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • RSV Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Early Detection and Diagnosis of Respiratory Syncytial Virus (RSV) Propels Market Growth
    • Increasing Use in Pediatric and Elderly Populations Expands Addressable Market Opportunity
    • Technological Advancements in Molecular and Point-of-Care Diagnostics Strengthen Market Position
    • Growing Focus on Preventing RSV-Related Complications Drives Adoption of Advanced Diagnostics
    • Surge in Demand for Rapid and Accurate RSV Testing Generates New Opportunities
    • Expanding Applications in Outpatient Clinics and Home Testing Throws Spotlight on Market Potential
    • Growth in Awareness and Screening Programs for Respiratory Infections Spurs Demand for RSV Diagnostics
    • Surge in Demand for RSV Testing During Flu Season and Outbreaks Expands Market Horizons
    • Growing Awareness of the Benefits of Early RSV Diagnosis in Reducing Hospitalizations Drives Market Adoption
    • Innovations in Portable and Digital Diagnostic Devices Generate New Market Opportunities
    • Rising Demand for RSV Diagnostics in Hospital and Ambulatory Care Settings Throws Spotlight on Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for RSV Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Kits & Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Kits & Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Kits & Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Rapid Antigen Detection Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Rapid Antigen Detection Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Rapid Antigen Detection Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World RSV Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • JAPAN
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • CHINA
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • EUROPE
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for RSV Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • FRANCE
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • GERMANY
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for RSV Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • INDIA
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for RSV Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for RSV Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • AFRICA
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030

IV. COMPETITION